Bayer stops blood thinner drug trial for lack of effect in major setback, World News - AsiaOne

Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion

Asia-Pacific countries begin to ease pandemic-related travel bans, but hurdles remain, World News - AsiaOne

North Koreans use fake names, scripts to land remote IT work for cash, World News - AsiaOne

Neo4j Signs Strategic Collaboration Agreement with AWS to Enhance Generative AI Results While Addressing AI Hallucinations, Business News - AsiaOne

Bayer woes pile up as blood thinner drug trial fails

McLaren boss says F1 budget cap breach amounts to cheating, World News - AsiaOne

Lingnan scholars listed in World's Top 2% Scientists by Stanford University, Business News - AsiaOne

Duchess Meghan sought advice from senior royals before writing letter to father, World News - AsiaOne

Covid-19 pill Paxlovid to be rolled out in phases: MOH, Singapore News - AsiaOne

Bayer shares plunge after blood-thinning drug trial halted

Millionaires group calls for wealth tax at WEF's virtual Davos summit, World News - AsiaOne

Bayer shares plunge after blood-thinning drug trial halted